PMID- 10319819 OWN - NLM STAT- MEDLINE DCOM- 19990520 LR - 20190705 IS - 0092-8674 (Print) IS - 0092-8674 (Linking) VI - 97 IP - 3 DP - 1999 Apr 30 TI - Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. PG - 395-406 AB - The amyloid-beta precursor protein (APP) is directly and efficiently cleaved by caspases during apoptosis, resulting in elevated amyloid-beta (A beta) peptide formation. The predominant site of caspase-mediated proteolysis is within the cytoplasmic tail of APP, and cleavage at this site occurs in hippocampal neurons in vivo following acute excitotoxic or ischemic brain injury. Caspase-3 is the predominant caspase involved in APP cleavage, consistent with its marked elevation in dying neurons of Alzheimer's disease brains and colocalization of its APP cleavage product with A beta in senile plaques. Caspases thus appear to play a dual role in proteolytic processing of APP and the resulting propensity for A beta peptide formation, as well as in the ultimate apoptotic death of neurons in Alzheimer's disease. FAU - Gervais, F G AU - Gervais FG AD - Department of Pharmacology, Biochemistry, and Molecular Biology, Merck Frosst Centre for Therapeutic Research, Merck Research Laboratories, Kirkland, Quebec, Canada. FAU - Xu, D AU - Xu D FAU - Robertson, G S AU - Robertson GS FAU - Vaillancourt, J P AU - Vaillancourt JP FAU - Zhu, Y AU - Zhu Y FAU - Huang, J AU - Huang J FAU - LeBlanc, A AU - LeBlanc A FAU - Smith, D AU - Smith D FAU - Rigby, M AU - Rigby M FAU - Shearman, M S AU - Shearman MS FAU - Clarke, E E AU - Clarke EE FAU - Zheng, H AU - Zheng H FAU - Van Der Ploeg, L H AU - Van Der Ploeg LH FAU - Ruffolo, S C AU - Ruffolo SC FAU - Thornberry, N A AU - Thornberry NA FAU - Xanthoudakis, S AU - Xanthoudakis S FAU - Zamboni, R J AU - Zamboni RJ FAU - Roy, S AU - Roy S FAU - Nicholson, D W AU - Nicholson DW LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Cell JT - Cell JID - 0413066 RN - 0 (Amyloid beta-Peptides) RN - 0 (Amyloid beta-Protein Precursor) RN - 0 (Cysteine Proteinase Inhibitors) RN - 0 (Enzyme Inhibitors) RN - 0 (Enzyme Precursors) RN - 0 (Excitatory Amino Acid Agonists) RN - 0 (Oligopeptides) RN - 0 (acetyl-aspartyl-glutamyl-valyl-aspartal) RN - 143313-51-3 (L 709049) RN - 30KYC7MIAI (Aspartic Acid) RN - EC 3.4.- (Amyloid Precursor Protein Secretases) RN - EC 3.4.- (Endopeptidases) RN - EC 3.4.22.- (CASP3 protein, human) RN - EC 3.4.22.- (Casp3 protein, mouse) RN - EC 3.4.22.- (Casp3 protein, rat) RN - EC 3.4.22.- (Caspase 3) RN - EC 3.4.22.- (Caspases) RN - EC 3.4.23.- (Aspartic Acid Endopeptidases) RN - EC 3.4.23.46 (BACE1 protein, human) RN - EC 3.4.23.46 (Bace1 protein, mouse) RN - SIV03811UC (Kainic Acid) RN - XT3Z54Z28A (Camptothecin) SB - IM MH - Acute Disease MH - Alzheimer Disease/*enzymology/genetics/pathology MH - Amyloid Precursor Protein Secretases MH - Amyloid beta-Peptides/genetics/*metabolism MH - Amyloid beta-Protein Precursor/genetics/*metabolism MH - Amyloidosis/*enzymology/genetics/pathology MH - Animals MH - Apoptosis/drug effects/genetics MH - Aspartic Acid MH - Aspartic Acid Endopeptidases MH - Brain Diseases/chemically induced/enzymology/pathology MH - Camptothecin/pharmacology MH - Caspase 3 MH - Caspases/analysis/*metabolism MH - Cysteine Proteinase Inhibitors/pharmacology MH - Endopeptidases/genetics MH - Enzyme Inhibitors/pharmacology MH - Enzyme Precursors/analysis/metabolism MH - Excitatory Amino Acid Agonists MH - Hippocampus/cytology MH - Humans MH - In Situ Nick-End Labeling MH - Kainic Acid MH - Leukemia, Erythroblastic, Acute MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Mutation/physiology MH - Neurons/chemistry/cytology/enzymology MH - Oligopeptides/pharmacology MH - Rabbits MH - Rats MH - Rats, Wistar MH - Sweden MH - Tumor Cells, Cultured EDAT- 1999/05/13 00:00 MHDA- 1999/05/13 00:01 CRDT- 1999/05/13 00:00 PHST- 1999/05/13 00:00 [pubmed] PHST- 1999/05/13 00:01 [medline] PHST- 1999/05/13 00:00 [entrez] AID - S0092-8674(00)80748-5 [pii] AID - 10.1016/s0092-8674(00)80748-5 [doi] PST - ppublish SO - Cell. 1999 Apr 30;97(3):395-406. doi: 10.1016/s0092-8674(00)80748-5.